{"id":904580,"date":"2025-11-03T17:48:54","date_gmt":"2025-11-03T22:48:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/"},"modified":"2025-11-03T17:48:54","modified_gmt":"2025-11-03T22:48:54","slug":"savara-announces-participation-in-upcoming-investor-healthcare-conferences-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/","title":{"rendered":"Savara Announces Participation in Upcoming Investor Healthcare Conferences"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Savara Announces Participation in Upcoming Investor Healthcare Conferences<\/b><\/p>\n<p>LANGHORNE, Pa.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fsavarapharma.com%2F&amp;esheet=54350781&amp;newsitemid=20251103285242&amp;lan=en-US&amp;anchor=Savara+Inc.&amp;index=1&amp;md5=a67874c9644ec5dcbe902924a2f57058\">Savara Inc.<\/a> (Nasdaq: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fsavarapharma.com%2F&amp;esheet=54350781&amp;newsitemid=20251103285242&amp;lan=en-US&amp;anchor=SVRA&amp;index=2&amp;md5=7937c17d250a7b12a3137be33cbdc0f0\">SVRA<\/a>) (the \u201cCompany\u201d), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced members of the management team will host 1&#215;1 meetings and participate in fireside chats at two upcoming healthcare conferences.<\/p>\n<p><b>Fireside Chats:<\/b><\/p>\n<p><b>Guggenheim 2<sup>nd<\/sup> Annual Healthcare Innovation Conference<br \/>\n<br \/><\/b>November 10, 2025, 8:30 a.m. ET<\/p>\n<p><b>Jefferies London Healthcare Conference<br \/>\n<br \/><\/b>November 19, 2025, 12:00 p.m. GMT<\/p>\n<p>\nThe live webcasts and subsequent replays will be available on the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.savarapharma.com%2Fevents-and-presentations%2Fdefault.aspx&amp;esheet=54350781&amp;newsitemid=20251103285242&amp;lan=en-US&amp;anchor=%26%238220%3BEvents+%26amp%3B+Presentations%26%238221%3B&amp;index=3&amp;md5=625401537a8fafc48a00f48e54bf108d\">\u201cEvents &amp; Presentations\u201d<\/a> section of the Company\u2019s corporate website and will be archived for 90 days.<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fsavarapharma.com%2Fabout-savara%2Four-company%2F&amp;esheet=54350781&amp;newsitemid=20251103285242&amp;lan=en-US&amp;anchor=About+Savara&amp;index=4&amp;md5=525cb03828d1ee4eddbe6d494ed49953\"><b>About Savara<\/b><\/a>\u00a0<\/p>\n<p>\nSavara is a\u00a0clinical stage\u00a0biopharmaceutical company focused on rare respiratory diseases. Our lead program,\u00a0MOLBREEVI*, is a recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (autoimmune PAP). MOLBREEVI\u00a0is delivered via\u00a0a proprietary\u00a0investigational\u00a0eFlow<sup>\u00ae<\/sup>\u00a0Nebulizer System (PARI Pharma GmbH) specifically developed for inhalation of\u00a0MOLBREEVI. Our management team has\u00a0significant experience\u00a0in rare respiratory diseases and pulmonary medicine,\u00a0identifying\u00a0unmet needs, and effectively advancing product candidates\u00a0to\u00a0approval and commercialization.\u202fMore information can be found at\u202f<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.savarapharma.com%2F&amp;esheet=54350781&amp;newsitemid=20251103285242&amp;lan=en-US&amp;anchor=www.savarapharma.com&amp;index=5&amp;md5=3510ebfc29b7b5c5448b7acd0ee44b3d\">www.savarapharma.com<\/a>\u00a0and\u00a0<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fsavara-pharmaceuticals&amp;esheet=54350781&amp;newsitemid=20251103285242&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=6&amp;md5=1804573722ed3b125474e99776be4204\">LinkedIn<\/a>.\u202f\u00a0\u00a0<\/p>\n<p><i>*MOLBREEVI is the FDA and EMA conditionally accepted trade name for molgramostim inhalation solution. It is not approved in any indication. MOLBREEVI is a trademark of Savara Inc.<\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251103285242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20251103285242\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20251103285242\/en\/<\/a><\/span><\/p>\n<p><b><span class=\"bwuline\">Media and Investor Relations Contact<br \/>\n<\/span><\/b><br \/>Savara Inc.<br \/>\n<br \/>Temre Johnson, Executive Director, Corporate Affairs<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:ir@savarapharma.com\">ir@savarapharma.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Pennsylvania<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Finance Health FDA Medical Devices Professional Services Clinical Trials<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251103285242\/en\/1383816\/3\/Savara_Logo_%28002%29.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Savara Announces Participation in Upcoming Investor Healthcare Conferences LANGHORNE, Pa.&#8211;(BUSINESS WIRE)&#8211;Savara Inc. (Nasdaq: SVRA) (the \u201cCompany\u201d), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced members of the management team will host 1&#215;1 meetings and participate in fireside chats at two upcoming healthcare conferences. Fireside Chats: Guggenheim 2nd Annual Healthcare Innovation Conference November 10, 2025, 8:30 a.m. ET Jefferies London Healthcare Conference November 19, 2025, 12:00 p.m. GMT The live webcasts and subsequent replays will be available on the \u201cEvents &amp; Presentations\u201d section of the Company\u2019s corporate website and will be archived for 90 days. About Savara\u00a0 Savara is a\u00a0clinical stage\u00a0biopharmaceutical company focused on rare respiratory diseases. Our lead program,\u00a0MOLBREEVI*, is a recombinant human granulocyte-macrophage colony stimulating &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Savara Announces Participation in Upcoming Investor Healthcare Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-904580","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Savara Announces Participation in Upcoming Investor Healthcare Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Savara Announces Participation in Upcoming Investor Healthcare Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Savara Announces Participation in Upcoming Investor Healthcare Conferences LANGHORNE, Pa.&#8211;(BUSINESS WIRE)&#8211;Savara Inc. (Nasdaq: SVRA) (the \u201cCompany\u201d), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced members of the management team will host 1&#215;1 meetings and participate in fireside chats at two upcoming healthcare conferences. Fireside Chats: Guggenheim 2nd Annual Healthcare Innovation Conference November 10, 2025, 8:30 a.m. ET Jefferies London Healthcare Conference November 19, 2025, 12:00 p.m. GMT The live webcasts and subsequent replays will be available on the \u201cEvents &amp; Presentations\u201d section of the Company\u2019s corporate website and will be archived for 90 days. About Savara\u00a0 Savara is a\u00a0clinical stage\u00a0biopharmaceutical company focused on rare respiratory diseases. Our lead program,\u00a0MOLBREEVI*, is a recombinant human granulocyte-macrophage colony stimulating &hellip; Continue reading &quot;Savara Announces Participation in Upcoming Investor Healthcare Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-03T22:48:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251103285242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Savara Announces Participation in Upcoming Investor Healthcare Conferences\",\"datePublished\":\"2025-11-03T22:48:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\\\/\"},\"wordCount\":275,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251103285242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\\\/\",\"name\":\"Savara Announces Participation in Upcoming Investor Healthcare Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251103285242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-11-03T22:48:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251103285242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251103285242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Savara Announces Participation in Upcoming Investor Healthcare Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Savara Announces Participation in Upcoming Investor Healthcare Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/","og_locale":"en_US","og_type":"article","og_title":"Savara Announces Participation in Upcoming Investor Healthcare Conferences - Market Newsdesk","og_description":"Savara Announces Participation in Upcoming Investor Healthcare Conferences LANGHORNE, Pa.&#8211;(BUSINESS WIRE)&#8211;Savara Inc. (Nasdaq: SVRA) (the \u201cCompany\u201d), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced members of the management team will host 1&#215;1 meetings and participate in fireside chats at two upcoming healthcare conferences. Fireside Chats: Guggenheim 2nd Annual Healthcare Innovation Conference November 10, 2025, 8:30 a.m. ET Jefferies London Healthcare Conference November 19, 2025, 12:00 p.m. GMT The live webcasts and subsequent replays will be available on the \u201cEvents &amp; Presentations\u201d section of the Company\u2019s corporate website and will be archived for 90 days. About Savara\u00a0 Savara is a\u00a0clinical stage\u00a0biopharmaceutical company focused on rare respiratory diseases. Our lead program,\u00a0MOLBREEVI*, is a recombinant human granulocyte-macrophage colony stimulating &hellip; Continue reading \"Savara Announces Participation in Upcoming Investor Healthcare Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-03T22:48:54+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251103285242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Savara Announces Participation in Upcoming Investor Healthcare Conferences","datePublished":"2025-11-03T22:48:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/"},"wordCount":275,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251103285242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/","name":"Savara Announces Participation in Upcoming Investor Healthcare Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251103285242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-11-03T22:48:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251103285242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251103285242r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/savara-announces-participation-in-upcoming-investor-healthcare-conferences-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Savara Announces Participation in Upcoming Investor Healthcare Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904580","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=904580"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904580\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=904580"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=904580"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=904580"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}